Evaluation of the Microbiome and Metabolome in IBS patients who use cannabis
Summary
Cannabis has long been used to treat abdominal pain and other gastrointestinal disorders and is commonly used by people with Irritable Bowel Syndrome (IBS) to manage their symptoms. Previous research has shown that cannabis components (THC and CBD) can influence our microbiome (bacteria and other microbes living in our gut). This research study is looking at how edible cannabis may affect the microbiome among adults with diarrhea predominant IBS (IBS-D).
We are recruiting 2 main groups of participants:
1. people with IBS-D who regularly use cannabis edibles
2. people with IBS-D who do not use cannabis at all
Participating in this study will only take a few hours in total. Everything can be done in your own home at your convenience.
What's involved?
1. Screening interview over the phone to ensure that all study inclusion and exclusion criteria are met, about 20-30 minutes.
2. Complete 6 questionnaires about symptoms related to your physical and mental health, about an hour.
3. Collect a stool sample with equipment provided
4. Write down a 24 hour diet diary the day before stool collection.
All questionnaires and required equipment will be mailed to you. After all study samples and questionnaires are completed, send back to the University using a pre-paid courier.
As a thank you for your time and effort, researchers will provide a $25 e-Gift Card (grocery store or coffee shop) after receipt of the completed questionnaires and collected stool sample.
Eligibility
Eligible ages: 18 to 80
Inclusion criteria:
1. Adult, 18 years old and older
2. Previous diagnosis of IBS-D by a healthcare professional
3a. Use cannabis edibles regularly
3b. Do not use cannabis at all
Exclusion criteria:
You are not eligible to participate if you:
1. Have a current diagnosis of IBS-C
2. Regularly use smoked or vaped cannabis
3. Have been previous diagnosed with celiac disease and/or inflammatory bowel disease
4. Are currently pregnant
5. Additional eligibility criteria will be reviewed during screening
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Lynn at lwilsack@ucalgary.ca
Principal investigator:
Yasmin Nasser
Clinical trial:
No
REB-ID:
REB20-1255
External links